First phase 3 trial of GLP-1 receptor agonist for neurodegeneration

Lancet. 2025 Feb 22;405(10479):598-599. doi: 10.1016/S0140-6736(25)00161-8. Epub 2025 Feb 4.
No abstract available

Publication types

  • Comment